跳至主要内容
临床试验/NCT01806363
NCT01806363已完成1 期

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interactions and Safety Between Telmisartan and Chlorthalidone in Healthy Male Volunteers.

HanAll BioPharma Co., Ltd.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Part A : AUC, Cmax of Telmisartan

研究概览

简要总结

Clinical trial to evaluate the pharmacokinetic interactions and safety between telmisartan and chlorthalidone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male subjects
  • Age(yr)between 20 and 50
  • Signed written informed consent

排除标准

  • Known hypersensitivity to investigator product, thiazide, sulphonamide and other drugs or additive.
  • History of any siginificant Sickness, Cardiovascular, Respiratory, Renal, Endocrine, Neurological, Psychic, Cancer, Gasstrointestinal, Hematologic.
  • History of drug and/or alcohol abuse
  • Over 10 tobaccos a day
  • Other condition which in the opinion of the investigator preclude enrollment into the study

研究组 & 干预措施

Part A: Telmisartan, Chlorthalidone + Telmisartan

Active Comparator

telmisartan 80mg : multiple dose administered orally chlorthalidone 25mg : multiple dose administered orally

干预措施: Telmisartan 80mg (Drug)

Part A: Telmisartan, Chlorthalidone + Telmisartan

Active Comparator

telmisartan 80mg : multiple dose administered orally chlorthalidone 25mg : multiple dose administered orally

干预措施: Chlorthalidone 25mg (Drug)

Part B: Chlorthalidone, Chlorthalidone + Telmisartan

Active Comparator

telmisartan 80mg : multiple dose administered orally chlorthalidone 25mg : multiple dose administered orally

干预措施: Telmisartan 80mg (Drug)

Part B: Chlorthalidone, Chlorthalidone + Telmisartan

Active Comparator

telmisartan 80mg : multiple dose administered orally chlorthalidone 25mg : multiple dose administered orally

干预措施: Chlorthalidone 25mg (Drug)

结局指标

主要结局

Part A : AUC, Cmax of Telmisartan

时间窗: Over a 24-hour sampling period

Part B : AUC, Cmax of Chlorthalidone

时间窗: Over a 24-hour sampling period

次要结局

  • Part A : Cmin, tmax, CL/F of Telmisartan(Over a 24-hour sampling period)
  • Part B : Cmin, tmax, CL/F of Chlorthalidone(Over a 24-hour sampling period)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验